5 results match your criteria: "The Joint Research Center for Human Retrovirus Infection Kumamoto University Campus[Affiliation]"
Primary care and sexual health services for transgender people in Japan are lacking. We surveyed 233 transgender patients (57 [24.5%] assigned male at birth [AMABs] and 176 [75.
View Article and Find Full Text PDFInduced lactation in a transgender woman: case report.
Int Breastfeed J
September 2024
The Nippon Foundation Human Milk Bank, Tokyo, Japan.
Background: Breastfeeding offers significant health benefits, but its practice and success can vary. While research on induced lactation in cisgender women has been documented, there is limited research on lactation induction in transgender women.
Case Presentation: A 50-year-old transgender woman undergoing hormone therapy and living with a pregnant partner sought to co-feed using induced lactation.
Local radiotherapy for chemotherapy-refractory Kaposi's sarcoma in an HIV-infected patient: A case report and literature review.
J Infect Chemother
October 2024
AIDS Clinical Center, National Center for Global Health and Medicine, 1-21-1 Toyama, Shinjuku ku, Tokyo, Japan; The Joint Research Center for Human Retrovirus Infection Kumamoto University Campus, Kumamoto City, Kumamoto, Japan. Electronic address:
Article Synopsis
- HIV-associated Kaposi's sarcoma (HIV-KS) is a tumor linked to HHV-8 infection, typically treatable with antiretroviral therapy (ART) and chemotherapy, though some cases resist treatment.
- A 58-year-old man with refractory HIV-KS faced complications after chemotherapy, which caused painful lesions that affected his ability to walk.
- Localized radiotherapy was used to treat his condition after ruling out metastases, leading to significant improvements in both appearance and mobility, suggesting a promising alternative for patients not responding to standard treatments.
Amebiasis as a sexually transmitted infection: A re-emerging health problem in developed countries.
Glob Health Med
December 2023
AIDS Clinical Center, National Center for Global Health and Medicine, Tokyo, Japan.
Amebiasis, which is caused by (), is the second leading cause of parasite-related death worldwide. It manifests from asymptomatic carriers to severe clinical conditions, like colitis and liver abscesses. Amebiasis is commonly seen in developing countries, where water and food are easily contaminated by feces because of the poor sanitation.
View Article and Find Full Text PDFPharmacokinetics of Bictegravir in Older Japanese People Living with HIV-1.
Microbiol Spectr
February 2023
AIDS Clinical Center, National Center for Global Health and Medicine, Shinjuku-ku, Tokyo, Japan.
Bictegravir (BIC) is an integrase strand transfer inhibitor widely used in the treatment of HIV-1. Although its potency and safety have been demonstrated in older patients, pharmacokinetics (PK) data remain limited in this patient population. Ten male patients aged 50 years or older with suppressed HIV RNA on other antiretroviral regimens were switched to a single-tablet regimen of BIC, emtricitabine, and tenofovir alafenamide (BIC+FTC+TAF).
View Article and Find Full Text PDF